AUPH
Aurinia Pharmaceuticals
$17.36
+$0.11 (+0.64%)Oct 28, 2026
Key metrics
The numbers that frame AUPH today
- Market cap
- $2.31B
- P/E (TTM)
- 7.6
- EV / FCF
- 12.5
- Gross margin
- 90.4%
- EV / Sales
- 7.0
- ROIC
- 28.2%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $11.96
- 52wk High
- $19.25
Growth
Revenue and earnings trend for AUPH
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AUPH
Is Aurinia Pharmaceuticals a good buy?
Yes. Aurinia Pharmaceuticals has strong quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Aurinia Pharmaceuticals is selling at a low price.
What is the market capitalization of AUPH?
Aurinia Pharmaceuticals's market capitalization is $2.31B.
What is the P/E (TTM) ratio for AUPH stock?
Aurinia Pharmaceuticals's P/E (TTM) ratio is 7.6, based on trailing earnings.
What is the 52-week high for AUPH stock?
The 52-week high for Aurinia Pharmaceuticals is $19.25. The current close of $17.36 is 9.8% below that high.
What is the 52-week low for AUPH stock?
The 52-week low for Aurinia Pharmaceuticals is $11.96. The current close of $17.36 is 45.2% above that low.
Does AUPH stock pay dividends?
Aurinia Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AUPH?
Aurinia Pharmaceuticals's Debt / Equity ratio is 0.1.